The Leadership Team at iECURE is responsible for shaping the strategic direction and operational execution of the company’s mission to develop innovative gene therapies for liver disorders. This multidisciplinary team, composed of executives with expertise in clinical trials, finance, regulatory affairs, and patient advocacy, ensures alignment between research initiatives and business objectives while fostering collaborations and guiding the clinical and technical strategies necessary for successful product development and commercialization. Together, they leverage their extensive experience to drive iECURE's goal of delivering transformative therapies to patients with significant unmet medical needs.
Alex Monteith
Chief Business Officer
David Garrett
CFO
Gabriel M. Cohn
Chief Medical Officer
George Diaz
VP, Therapeutic Area Lead, Ure...
Joseph Truitt
CEO
Kimberly M. Smith
VP, Finance & Accounting
Mark J. Semanick
VP, Head of Technical Operatio...
Maryann A. Toto
VP, Head of Regulatory Affairs
Matthew Hall
VP, Head of Clinical Operation...
Paul Firuta
COO